Work

Phase I/II study of T-DM1 alone versus T-DM1 and metronomic temozolomide in secondary prevention of HER2-positive breast cancer brain metastases following stereotactic radiosurgery.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.tps2572

Authors: Alexandra Dos Santos Zimmer, Seth M. Steinberg, DeeDee Kay Smart, Mark R. Gilbert, Terri Armstrong, Eric Burton, Nicole D. Houston, Nadia Biassou, Brunilde Gril, Priscilla Kaliopi Brastianos, Scott L Carter, David Lyden, Stanley Lipkowitz, Patricia Schriver Steeg

Institutions: National Cancer Institute, Center for Cancer Research, National Institutes of Health, Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute, Weill Cornell Medicine

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3028748510

Cites:

Cited by:

Related to: 10